Keep in mind that the stock has declined on the day after the release of the company's last five earnings reports. The declines ranged from 2.4% on May 3, 2024, to 15.3% on Oct. 31, 2024, with an ...

Apellis Pharmaceuticals said it has received approval from the Food and Drug Administration for Empaveli, its treatment for rare kidney diseases.

In the wake of the Trump administration's trade deal with the European Union, investors have turned to watching for other agreements ahead a deadline at the end of this week - and they're looking for ...

'If my salary had kept pace with inflation, I would be earning an additional $17,000 a year' ...

J.P. Morgan's Boss raised his rating on the stock to overweight, after being at neutral for the past 13 months. He also boosted his stock-price target to $93 from $64, with the new target implying ...

Irving may have been referring to how athletes have been targeted in robberies or scams, possibly due to their public salaries. NBA players like Luka Doncic, Mike Conley, DeMar DeRozan and Kentavious ...

Beyond Inc. (BYON) reported second-quarter revenue of $282 million, down 29.1% year over year, but above FactSet forecasts for $250 million. The company reported an adjusted loss per share of 22 cents ...

The IPC Indice de Precios Y Cotizaciones is down 239.58 points or 0.42% today to 57083.56 --Largest one-day point and percentage decline since Tuesday, July 22, 2025 ...

Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...

--Year-to-date the dollar is down 9.88% vs the Mexican peso The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such ...

Dollar/Canadian dollar: 1.3741 Canadian dollars per dollar (0.7278 dollar per Canadian dollar) --Today the dollar gained 0.28% vs. the Canadian dollar ...

Tariffs might be pushing Walmart Inc.'s prices higher, but the big-box chain hasn't seen any "major shifts" in shoppers' behavior, and it is likely to pick up more of those consumers, since it isn't ...